[18F]‐NOTA‐FAPI‐04 PET/CT downgraded the staging of a breast cancer patient and changed their treatment management

[18F]‐NOTA‐FAPI‐04 PET/CT downgraded the staging of a breast cancer patient and changed their treatment management

Abstract A 47‐year‐old woman underwent [18F]‐FDG and [18F]‐NOTA‐FAPI‐04 PET/CT to assess the staging of suspected axillary lymph node enlargement following breast‐conserving surgery. The imaging with these two PET agents revealed starkly contrasting results. Significant [18F]‐FDG uptake in the right...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingjie Qin, Jingjing Zhao, Jinming Yu, Yuchun Wei
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Precision Radiation Oncology
Subjects:
breast cancer
fibroblast activation protein
PET
Online Access:https://doi.org/10.1002/pro6.1245
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items